The pharma redemption, in four acts
For Hollywood scriptwriters, the villain-to-hero arc is a familiar one. The challenges characters must go through in their arc of redemption can help pharmaceutical brands navigate this next year in the spotlight.
Pharma
A tale of two drug launches during coronavirus
Two pharma companies on rethinking drug launches during COVID-19.
Infographic: Most consumers OK with pharma continuing to advertise during COVID-19
A report from CMI/Compas evaluated consumers’ changing habits during the COVID-19 pandemic.
Marketers share specialty pharma campaigns with strong results
Marketers from GoodRx and Rx Edge Media Network share their insights.
Pharma ad spend 2019: TV drug ad plateau
The data is in for 2019, and we break down the ad dollars being spent in different media and also look at the top brands.
The secrets behind 3 successful pharma podcasts
Deep content dives. Big listener numbers. Minimal meddling. Eli Lilly, Genentech and Pfizer share the secrets behind their podcast successes.
Trump and officials meet with pharma on coronavirus treatments
President Trump wanted to know how quickly pharma could have a vaccine or treatment ready for public use.
Pharma comms exec Jeff Winton launches agency
Winton previously led corporate communications and public affairs functions at Alkermes and Astellas.
Pharma Q4 earnings roundup
Merck announced a spin-off of its biosimilar, women’s health and legacy products.
Real-world patient data is revolutionizing clinical trials
The FDA granted Pfizer’s Ibrance a label indication based on real-world data from men using the drug off-label to treat their breast cancer.
